The short version of immunomodulation fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-09-28. Anything still debated is marked as such rather than presented as settled.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Identity and purity are normally assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and truncation products. Mass spectrometry confirms molecular mass and detects modifications such as deamidation or oxidation. Amino acid analysis and peptide mapping provide additional sequence-level confirmation. For research material, a certificate of analysis typically reports these results together with water content and counter-ion identity, since the lyophilized powder is often supplied as an acetate or trifluoroacetate salt.
Several factors accelerate degradation: alkaline pH, elevated temperature, exposure to oxidants, and the presence of residual moisture. Deamidation of asparagine residues and oxidation of methionine are the most commonly reported degradation routes. Because the peptide lacks disulfide bonds, it does not undergo the thiol-related aggregation seen in some other biologics, but physical aggregation can still occur at high concentration. Stability data are product-specific, and extrapolating shelf life between formulations is not reliable.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | ≈3,108 Da | Synthetic 28-residue peptide |
| Amino acid count | 28 | N-terminal serine carries an acetyl group |
| Appearance | White to off-white powder | Lyophilized solid |
| Water solubility | Freely soluble | Dissolves in aqueous buffer |
| Common synonyms | Thymalfasin; Tα1 | Thymalfasin is the international nonproprietary name |
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
The compound has been investigated as an adjunct in chronic viral hepatitis and as a vaccine adjuvant, with results that vary by study design and population. Regulators in some countries have approved a synthetic form for specific indications, while other agencies have not. Whether the peptide produces consistent clinical benefit across diverse patient groups is still an open question, and many trials have been small. Its status is therefore best described as investigational in many contexts and established only narrowly.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
== Units and unit conversions == The serum concentration of prolactin can be given in mass concentration (μg/L or ng/mL), molar concentration (nmol/L or pmol/L), or international units (typically mIU/L). The current IU is calibrated against the third International Standard for Prolactin, IS 84/500. Reference ampoules of IS 84/500 contain "approximately" 2.5 μg of lyophilized human prolactin and have been assigned an activity of 0.053 International Units by calibrating against the previous standard. Measurements can be converted into mass units using this ratio of grams to IUs to obtain an equivalent in relationship to the contents of IS 84/500; prolactin concentrations expressed in mIU/L can be converted to μg/L of IS 84/500 equivalent by dividing by 21.2. Previous standards had other ratios in relation to their potency on the assay measurement. For example, the previous IS (83/562) had a potency of 27.0 mIU per μg. The first International Reference Preparation (or IRP) of human Prolactin for Immunoassay was established in 1978 (75/504 1st IRP for human prolactin) at a time when purified human prolactin was in short supply. Previous standards relied on prolactin from animal sources. Purified human prolactin was scarce, heterogeneous, unstable, and difficult to characterize. A preparation labeled 81/541 was distributed by the WHO Expert Committee on Biological Standardization without official status and given the assigned value of 50 mIU/ampoule based on an earlier collaborative study.
=== Dendrimers === Dendrimers are unique hyper-branched synthetic polymers with monodispersed size, well-defined structure, and a highly functionalized terminal surface. They are typically composed of synthetic or natural amino acid, nucleic acids, and carbohydrates. Therapeutics can be loaded with relative ease onto the interior of the dendrimers or the terminal surface of the branches via electrostatic interaction, hydrophobic interactions, hydrogen bonds, chemical linkages, or covalent conjugation. Drug-dendrimer conjugation can elongate the half-life of drugs. Currently, dendrimer use in biological systems is limited due to dendrimer toxicity and limitations in their synthesis methods. Dendrimers are also confined within a narrow size range (<15 nm) and current synthesis methods are subject to low yield. The surface groups will reach the de Gennes dense packing limit at high generation level, which seals the interior from the bulk solution – this can be useful for encapsulation of hydrophobic, poorly soluble drug molecules. The seal can be tuned by intramolecular interactions between adjacent surface groups, which can be varied by the condition of the solution, such as pH, polarity, and temperature, a property which can be utilized to tailor encapsulation and controlled release properties.
== Regulation == Speculation on the power of systems that have been called "molecular assemblers" has sparked a wider political discussion on the implication of nanotechnology. This is in part due to the fact that nanotechnology is a very broad term and could include "molecular assemblers". Discussion of the possible implications of fantastic molecular assemblers has prompted calls for regulation of current and future nanotechnology. There are very real concerns with the potential health and ecological impact of nanotechnology that is being integrated in manufactured products. Greenpeace for instance commissioned a report concerning nanotechnology in which they express concern into the toxicity of nanomaterials that have been introduced in the environment. However, it makes only passing references to "assembler" technology. The UK Royal Society and Royal Academy of Engineering also commissioned a report entitled "Nanoscience and nanotechnologies: opportunities and uncertainties" regarding the larger social and ecological implications of nanotechnology. This report does not discuss the threat posed by potential so-called "molecular assemblers".
== Public listing, financials and governance == TCI is listed on Taiwan's OTC market (stock code 8436). Regulatory and investor pages report the company's registration details, public offering timeline (public offering 25 August 2011; OTC listing 12 September 2013), paid-in capital and disclosure contacts. Quarterly and annual reports are published on the company's investor relations pages.
Sources: en.wikipedia.org
=== Chemistry === Pure lisinopril powder is white to off-white in color. Lisinopril is soluble in water (approximately 13 mg/L at room temperature), less soluble in methanol, and virtually insoluble in ethanol.
=== Additional doses === Immunity following a course of doses is typically long lasting, and additional doses are usually not needed unless the person has a high risk of contracting the virus. Those at risk may have tests done to measure the amount of rabies antibodies in the blood, and then get rabies boosters as needed. Following administration of a booster dose, one 2002 study found 97% of immunocompetent individuals demonstrated protective levels of neutralizing antibodies after ten years. A 2021 study found that in patients who had received PrEP rabies vaccines in the form of 2 doses or 3-doses 10-24 years ago, rabies immunological memory was reactivated in all patients within 7 days after a single intramuscular booster immunization. The WHO recommends that patients who had received at least 2 doses of PrEP in the past be given after exposure either of the following three approved protocols of rabies vaccine booster administration: 1-site ID on days 0 and 3; or 4-sites ID on day 0; or 1-site IM on days 0 and 3. RIG should not be given to patients who had undergone PrEP.
==== Contact with anti-Chiang organizations ==== Liu was reportedly influenced by the Xi'an Incident and the formation of the Second United Front in 1936, noting that the Communist Party was emerging as a major force in the country. In 1938, Liu Wenhui then reportedly established contact with the Communist Party's Southern Bureau through his in-laws, including general Zhang Zhihe. Zhang Zhihe would become a member of the Central Committee of the China Democratic League (CDL). Another CDL Central Committee member he was in close contact with was Zheng Shufan. Around the time of its establishment in 1941, Liu began providing financial support to the CDL. In September 1944, Liu joined the China Democratic League, becoming a Central Committee member in 1945. Liu's membership, influenced by fellow Sichuan native and CDL chairman Zhang Lan, was kept secret. Peng Dixian, who would later become one of Liu's main biographers, asserts that he established a branch of the CDL in Xikang under Liu's auspices, serving as its chairman. Liu and the CDL would cooperate closely during the later Chengdu Uprising. Over the course of the war with Japan, Liu had also been in contact with generals Li Jishen and Feng Yuxiang, who established the Revolutionary Committee of the Chinese Kuomintang (RCCK) in January 1948. On the urging of Li Jishen, Liu joined in the summer of 1948 as an underground member of the RCCK, becoming the Chairman of its Sichuan branch.
===== Cryopreserved platelets ===== Cryopreserved platelets are platelet components frozen for long-term storage, typically using dimethyl sulfoxide as a cryoprotectant. They have been investigated as an alternative to conventional liquid-stored platelets, which have a short shelf life of approximately 5 to 7 days. The longer shelf life of cryopreserved platelets may be useful in settings where maintaining liquid-stored platelets is difficult. A CLIP-II randomized clinical trial found that cryopreserved platelets did not meet the criterion for noninferiority compared with liquid-stored platelets for bleeding control in cardiac surgery, although no increase in prespecified adverse events was observed. A trial-based economic evaluation alongside CLIP-II found that cryopreserved platelets were more costly and less effective than liquid-stored platelets for treating active bleeding in patients undergoing cardiac surgery in tertiary Australian hospitals.
== Criticisms == Yu managed to become a household name in China because she abridged the works of Confucius (551-479 B.C.) and Zhuangzi (369-286 B.C.) to make it appear relevant to laymen with "colloquial re-wordings and vivid short stories". In an interview with New York Times, Yu attributed the popularity of her work to the stresses of life in the fast-changing nation and to historical factors (paraphrased): "Traditional thought has been criticized for so many years that there is genuine interest in rediscovering it." On the Baidu (《百度》) portal alone, there are over 20,000 posts on the "bulletin board" named after her. "White collar workers, college students, professors, migrant workers, community guards and retired grannies all had something to say." Christian Caryl, writing in Hong Kong's Muse Magazine, has criticised Yu's book Confucius from the heart: Ancient Wisdom for Today's World: 'New-Agers in the West have made an industry out of freeze-drying non-Western religions until they're tasteless enough for the indiscriminate modern palate. Yu's book is the first time I've seen a non-Westerner up to the same sort of thing.'
Sources: en.wikipedia.org
It is a chain of 28 amino acids, with an acetyl group attached to the first serine residue. The synthetic version replicates this sequence. Its molecular mass is about 3,108 daltons.
It is usually described as an immunomodulatory peptide rather than a classic hormone. It acts on immune cells through receptor pathways. No single endocrine organ target defines its function.
Several countries, including Italy and China, allow it for specific indications. The FDA has not approved it as a drug in the United States. Availability depends on local regulation.
Dry lyophilized powder tolerates short ambient exposure during handling and shipping. Long-term room-temperature storage is not recommended because moisture uptake and slow degradation can occur over months. Storage at minus twenty degrees Celsius is the common practice for extended periods.